GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

GlobalTech Corp. (OTC: GLTK), closed Tuesday's trading session at $1.56, up 19.084%, on 3,100 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.1/$3.4.

Recent News

• GlobalTech Corp. (OTC: GLTK) - InvestorNewsBreaks - GlobalTech Corp. (OTC: GLTK) Approved For OTCQB Venture Market Listing
• Anthropic Claims Chinese AI Companies are "Distilling" Claude
• Dutch Air Force Tests AI Simulators That React to Pilots' Brain Activity

MindWave Innovations Inc. (NYSE American: APUS)

The QualityStocks Daily Newsletter would like to spotlight MindWave Innovations Inc. (NYSE American: APUS).

MindWave Innovations Inc. (NYSE American: APUS) is a digital asset and technology company providing institutional-grade treasury infrastructure for the digital asset economy. The company offers a secure and compliant gateway to digital assets through insured custody solutions, AI-enabled yield strategies, and transparent reporting systems. MindWave is focused on supporting corporations and institutional counterparties in holding, managing, and generating risk-aware yield on Bitcoin reserves through a disciplined, technology-driven platform.

The company’s strategy is built around a multi-vertical ecosystem that integrates Bitcoin-based treasury infrastructure with AI-driven yield capabilities, digital engagement platforms, and sustainability-focused systems. Its platform is designed to support both institutional participants—through compliant, insured digital asset management and treasury solutions—and a broader community through a decentralized, token-driven ecosystem enabling governance, staking, and access to financial services. This approach is supported by a blockchain-enabled architecture designed to align economic incentives, governance, and value flow across its operations through the use of its native token, $NILA.

Following a strategic business combination, the company now operates as a publicly traded platform positioned at the intersection of digital assets, artificial intelligence, and decentralized systems. Its structure brings together institutional treasury solutions with a broader ecosystem designed to support yield generation, governance, and real-world utility.

The company is headquartered in Delaware.

Products

The company’s operations are centered on MindWaveDAO, a decentralized ecosystem developed through its UAE-based subsidiary and designed to integrate multiple functional verticals into a unified blockchain-enabled platform.

At the core of the ecosystem is a Bitcoin-based yield infrastructure that underpins financial activity across the platform, supporting yield generation, staking mechanisms, and overall economic sustainability. This foundation is complemented by an institutional-grade treasury framework that enables corporations to directly hold digital assets through segregated, board-controlled custody structures designed to align with corporate governance and compliance requirements.

The broader platform architecture includes multiple integrated components designed to support institutional and on-chain financial activity. These include a proprietary Layer-2 blockchain (“MindChain”) engineered for real-world asset tokenization and scalable decentralized finance applications; a multi-layered security framework incorporating distributed key management, insured custody structures, and policy-based controls; and a validator node infrastructure that supports Proof-of-Stake networks while generating recurring, protocol-driven yield.

In addition, the platform incorporates an AI-powered yield engine that leverages data ingestion, signal generation, and automated strategy execution to identify market opportunities and manage risk across digital asset markets. This system supports a diversified, multi-strategy approach that includes derivatives-based income strategies, liquidity provisioning, and volatility-driven trading.

On top of this infrastructure, the ecosystem is organized across four primary application verticals:

• AdTech (Wave+): A platform that converts digital engagement into tokenized incentives through a tap-to-earn model tied to sustainability-linked activities, enabling users to earn rewards through participation in tasks and interactions.
• InsurTech: A hybrid framework combining on-chain smart contract mechanisms with traditional underwriting structures to provide protection for digital assets and address risks associated with volatility and custody.
• AI Governance: A cognitive analytics layer designed to support decision-making, strategic analysis, and governance participation by providing structured insights and analytical tools within decentralized environments.
• ClimateTech (Aquae Impact): A system focused on the tokenization of ecological and carbon-related assets, enabling transparent and auditable tracking of environmental impact through blockchain-based verification.

Across all verticals, the $NILA token functions as the central economic layer, facilitating governance participation, staking, service activation, and interoperability throughout the ecosystem.

Market Opportunity

The company operates at the convergence of several large and rapidly growing markets, including decentralized finance, digital advertising, artificial intelligence, insurance technology, and sustainability-focused finance.

The decentralized finance (DeFi) market continues to expand, with total value locked expected to reach hundreds of billions, supporting growth in yield generation and decentralized financial infrastructure, while global digital advertising spend is projected to surpass $650 billion, reflecting increasing demand for transparency, performance alignment, and measurable engagement outcomes.

At the same time, demand for digital asset insurance solutions is increasing alongside the growth and volatility of cryptocurrency markets, artificial intelligence is projected to generate trillions in economic impact across industries, and climate finance markets are expanding as regulatory pressures and investor demand drive interest in transparent, ESG-aligned investment opportunities.

Leadership Team

Dr. Vin Menon, CEO of MindWaveDAO, is a globally recognized blockchain strategist and social entrepreneur committed to applying technology to sustainable development initiatives. He leads the company’s vision of building an institutional-grade digital treasury and yield ecosystem that integrates decentralized finance with real-world utility and environmental alignment. In addition to his role at MindWaveDAO, he is Co-founder and CEO of AQUAE, where he developed a framework for transforming ecological assets into measurable and tradable digital instruments, and he has advised and supported multiple ventures across Web3, DeFi, and digital asset markets.

Capt. Sandeep Yadav, COO of MindWaveDAO, brings more than 20 years of experience across financial markets, fintech, and global operations, with a background spanning maritime leadership, regulatory compliance, and sustainability-focused strategy. He has held senior operational roles across international shipping and logistics, overseeing complex global operations and compliance frameworks, and currently contributes to strategy and climate-focused initiatives through his work with Aquae Labs and related organizations.

Amardeep Singh, CTO of MindWaveDAO, has over 27 years of experience in the technology industry, including more than eight years specializing in blockchain systems. His background includes work across satellite communications, healthcare, and fintech, where he has led the design and implementation of enterprise-scale systems, with expertise in IT security, technical architecture, and the delivery of complex, cross-functional technology solutions.

MindWave Innovations Inc. (NASDAQ: APUS), closed Tuesday's trading session at $1.88, even for the day. The average volume for the last 3 months is 93,401 and the stock's 52-week low/high is $0.951/$4.031.

Recent News

• MindWave Innovations Inc. (NYSE American: APUS) - MindWave Innovations Inc. (NYSE American: APUS) Is 'One to Watch'
• Apimeds Pharmaceuticals and Lokahi Therapeutics Announce FDA Type C Meeting Scheduled for LT-100 (Apitox)
• E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Tuesday's trading session at $4, up 7.2386%, on 6,250 volume. The average volume for the last 3 months is 13,655 and the stock's 52-week low/high is $3.42/$11.6779.

Recent News

• Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch
• BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line
• BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF).

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) is a junior exploration company focused on exploring and advancing an organic sedimentary raw rock phosphate project in northeast Nevada. The company’s business model centers on developing a rare, direct-application phosphate product that aligns with the growing demand for organic agricultural inputs. Its vision is to support the rapidly expanding organic food industry with a clean, reactive, environmentally responsible nutrient source that avoids the contamination issues associated with chemically processed fertilizers.

NOP is advancing the Murdock Mountain Project through disciplined exploration, responsible environmental practices, and strategic planning that positions the company as a future supplier of organic phosphate to key agricultural markets. The company emphasizes transparency, environmental stewardship, and adherence to regulatory standards as it advances its drill program and project development.

By developing a unique phosphate resource in a mining-friendly U.S. jurisdiction with strong infrastructure access, NOP aims to establish itself as a significant participant in the organic fertilizer sector.

The company is headquartered in Vancouver, British Columbia.

The Murdock Mountain Phosphate Project

NOP’s flagship asset is the Murdock Mountain Phosphate Project in Elko County, Nevada, a nearly flat-lying sediment-hosted phosphate system traced historically over 6.6 kilometers and extended through additional applications to more than 30 kilometers. The project’s raw rock phosphate is characterized by high purity, absence of heavy metals, and suitability for direct application without processing, aided by francolite (the most reactive crystallite structure of all P₂O₅ minerals) and oolitic textures that provide optimal surface area for interaction with soil micro-organisms. The product’s purity places it within the rare 5% of global P₂O₅ material pure enough for direct field application.

The Murdock Mountain property spans four Bureau of Land Management (BLM) applications totaling 7,824 acres, with an Exploration Target Mineral Inventory (ETMI) of 10–46 million tonnes in the initial 1,813-acre area and an additional 200–220 million tonnes across three further applications. Historic geologic mapping and recent drilling identify the Upper Phosphatic Zone within the Meade Peak Member as the primary target, with an interval historically ranging from 3.4 to 7.6 meters thick within a 28–40-meter phosphatic sequence.

In 2025, NOP commenced a multi-hole drill program with unrestricted seasonal timing following regulatory updates. Drill holes MM25-1, MM25-2, MM25-3, MM25-4 and MM25-5 all intersected favorable Meade Peak phosphate-bearing stratigraphy precisely where predicted by geological modeling. These intersections ranged from 29.2 to 38 meters (96 to 125 feet), with drilling confirming the interpreted dip and continuity of the target zone. Ongoing step-out drilling continues along the phosphate trend, supported by geological mapping and XRF screening, with assays pending. The project benefits from proximity to Highway SR 30, the hamlet of Montello, and the Southern Pacific rail line, enabling a simple mining concept summarized by: “break it up, dig it up, grind it up, bag it up, and ship it out.”

Market Opportunity

NOP intends to supply organic, direct-application phosphate fertilizer to the rapidly expanding organic food sector in North America. The company cites a $35 billion organic food market, supported by data from the U.S. Department of Agriculture’s Economic Research Service, which estimated an 8.7% annual growth rate between 2021 and 2027.

The shift toward organic and regenerative agriculture is driving demand for reactive, non-acidulated phosphate sources, and NOP notes that American farming practices are increasingly moving toward direct-application phosphate rather than soluble chemical fertilizers. With only 5% of global P₂O₅ pure enough for direct application, the company is targeting a rare, high-value segment of the fertilizer market that does not require competition with conventional chemical fertilizer producers.

Leadership Team

Robin Dow, Chairman & CEO, brings extensive experience as a public venture capital entrepreneur, following prior roles as a retail and institutional broker and researcher at Burns Fry. He has created more than 30 private and public companies across multiple sectors, raised close to $200 million, and built resource operations spanning four continents, 10 countries, four U.S. States, four Canadian provinces, and three Canadian territories.

Eric Szustak, Director, offers over 39 years of financial services, accounting, business development, and marketing experience, supported by senior roles at firms including Midland Walwyn, Merrill Lynch, and BMO Nesbitt Burns. He is the former President and current Chairman of Quinsam Capital Corporation and holds multiple directorships in publicly listed companies.

Garry K. Smith, Director, contributes more than 40 years of exploration management for companies such as Kerr Addison, Teck, Rio Tinto, and Lac Minerals. As a Qualified Person, he specializes in project generation, 43-101 reporting, resource evaluation, geological modeling, and metal ion soil geochemistry, with a strong focus on ethical and environmentally responsible exploration practices.

Paul W. Pitman, P.Geo., Director, is a field hardened veteran with extensive experience in all areas of geological exploration for a number of metals and materials. He has over 55 years’ experience as an exploration geologist. Since 1983, he has acted as a geological consultant to over 70 clients, providing a full range of services (geological, corporate, and administrative). He has served as a Director or Officer (VP or President) of several junior resource companies, including Boreal Agrominerals, a producer off organic fertilizers from igneous rock in Northern Ontario. He is semi-retired but directs his geological expertise as an advisor to several fertilizer companies.

Nevada Organic Phosphate Inc. (OTCQB: NOPFF), closed Tuesday's trading session at $0.1238, up 4.4726%, on 104,380 volume. The average volume for the last 3 months is 416,490 and the stock's 52-week low/high is $0.0334/$0.3212.

Recent News

• Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) - Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Targets Supply Gap in Fertilizer for Expanding Organic Food Market
• MiningNewsBreaks - Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Advances Murdock Mountain Program Following Wildlife Survey Clearance
• InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Provides Update On Murdock Mountain Drilling Timeline

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF)

Disseminated on behalf of ShelfieTech Ltd., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF).

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) is a technology company dedicated to transforming retail inventory management through automation and modern engineering. The company’s vision centers on simplifying the future of retail by reducing the friction between people, shelves and data, enabling retailers to operate with greater reliability and responsiveness. Its mission is to create technology that elevates store performance while supporting employees with tools that remove unnecessary manual tasks.

Built on values of consideration, collaboration and efficiency, ShelfieTech focuses on solutions that enhance both operational flow and the human–technology relationship. The company emphasizes user-friendly design and thoughtful automation, ensuring that store teams are empowered rather than replaced. This value-driven approach guides every product and workflow the company develops.

Through this philosophy, ShelfieTech aims to help retailers deliver consistently stocked shelves, smoother operations and improved customer experiences across major grocery and supermarket environments.

The company is headquartered in Vancouver, British Columbia.

Products

ShelfieTech offers a comprehensive retail-inventory management platform built around a robotic shelf-monitoring system powered by proprietary software. The system uses machine learning and computer-vision algorithms to capture high-resolution images across shelves, providing precise, real-time insights into product quantity, identification and placement. With scheduled or on-demand scanning, retailers can generate up-to-date shelf data whenever needed.

The company’s technology supports flexible configuration, plug-and-play installation and seamless integration across store environments. Its AI-driven identification engine classifies products, monitors stock levels with accuracy and helps managers optimize both shelf organization and broader capacity planning. The solution enhances retail workflow efficiency by automating the most tedious and error-prone parts of inventory management.

To support in-store teams, ShelfieTech offers a dedicated mobile app for employees, enabling smarter task organization, daily planning and status updates. Managers can access the company’s cloud-based dashboard for a remote, real-time overview of store conditions, empowering data-backed decision-making from any location. Additional features include dynamic advertising screens on the scanner and motion-sensing safety technology that pauses device movement when customers are nearby.

Market Opportunity

ShelfieTech addresses critical inefficiencies in traditional retail inventory management. Human-performed inventory counts average only 63% accuracy, contributing to operational inconsistencies and product shortages. Approximately 46% of inventory errors result directly from manual processes, and 25% of consumers respond negatively when items are out of stock — a factor that directly affects sales and customer loyalty.

These operational challenges create strong market demand for automated solutions that ensure real-time shelf visibility and maintain product availability. As retailers seek to streamline workflows, reduce labor burdens and improve inventory reliability, technologies that combine AI, robotics and automated scanning are becoming increasingly important. ShelfieTech’s platform aligns directly with this industry shift by providing precise, continuous shelf monitoring that helps retailers avoid revenue loss tied to stockouts and inefficient processes.

Leadership Team

Bentsur Joseph, Founder, CEO and Chairman, is a serial entrepreneur with a strong track record in building and expanding successful corporations. He previously served as Chairman of Elad Hotels (part of the Tshuva Group, one of Israel’s largest conglomerates) and held a director position at MARLAZ, a public holding company involved in industrial, real estate, communication, and high-tech sectors. Earlier in his career, he was Operations Manager at Comfy Interactive Movies, a leading publicly traded edutainment company.

Alan Rootenberg, CFO & Corporate Secretary, is a CPA, CA with more than 35 years of experience in business development, senior management, accounting, corporate finance and corporate administration. He oversees financial operations, reporting and corporate governance for the company.

ShelfieTech Ltd. (OTCQB: SHLFF), closed Tuesday's trading session at $1.085, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $1.01/$1.5.

Recent News

• ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) - NetworkNewsBreaks - ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Advancing Robotic System on Heels of Significant Progress
• InvestorNewsBreaks - Why ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Is 'One to Watch'
• ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Expands Real-Time Shelf Visibility Tools to Transform Global Retail Management

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

• Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
• Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
• Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Massimo Group (NASDAQ: MAMO), closed Tuesday's trading session at $0.9942, up 3.7137%, on 44,707 volume. The average volume for the last 3 months is 140,617 and the stock's 52-week low/high is $0.85/$5.59.

Recent News

• Massimo Group (NASDAQ: MAMO) - Polestar 3 EVs to Be Exclusively Made in the US
• MissionIRNewsBreaks - Massimo Group (NASDAQ: MAMO) Reports 2025 Results, Expands Margins Amid Strategic Shift
• Oil Shock Triggers Surge in Global Chinese EV Exports

Xeriant Inc. (OTCQB: XERI)

The QualityStocks Daily Newsletter would like to spotlight Xeriant Inc. (OTCQB: XERI).

Xeriant Inc. (OTCQB: XERI) is dedicated to the discovery, development and commercialization of emergent, transformative technologies, focusing on eco-friendly advanced materials with applications across multiple industries.

The company builds its technology portfolio through strategic partnerships, acquisitions, and internal development programs, emphasizing diversification and synergy, and is supported by its innovation platform called Factor X Research Group. Xeriant’s affiliated entities maintain operational focus and expertise while becoming part of a collaborative interdisciplinary innovation hub aimed at enhancing capabilities and accelerating technology development and deployment.

Xeriant’s advanced materials line is marketed under the DUREVER™ brand and includes NEXBOARD™, a patent-pending composite construction panel made from recycled plastic and fiber waste, designed to replace drywall, plywood, OSB, MDF, MgO board and other construction panels.

The company is headquartered in Boca Raton, Florida.

Portfolio

NEXBOARD™

Xeriant’s primary commercial focus is NEXBOARD™, an eco-friendly composite construction panel made from recycled plastic and fiber waste and enhanced with the company’s proprietary nanotechnology-based fire retardant, marketed under the DUREVER™ brand. Internal tests have demonstrated exceptional fire resistance, including a five-minute torch test reaching up to 2,500ºF and an 80-minute high-heat evaluation exceeding 2,000ºF.

The company has completed multiple limited production runs and internal tests to support certification, with accredited agencies documenting materials, processes, and quality controls. Upcoming certification testing includes NFPA 286 and ASTM E84, along with structural and durability testing.

Factor X Research Group

Factor X is Xeriant’s advanced innovation division, established to accelerate high-impact technologies from concept to commercial deployment. Modeled after Lockheed’s Skunk Works™, the group brings together experts across advanced materials, aerospace, artificial intelligence, critical infrastructure, and related disciplines to streamline development and strengthen cross-functional collaboration.

Its expanded mandate includes identifying acquisition opportunities; targeting disruptive technologies in areas such as AI, quantum computing, and data science; and supporting products like NEXBOARD™ as they move through the company’s commercialization pipeline.

Under the leadership of Brig. Gen. (Ret.) Blaine D. Holt, Factor X provides a coordinated environment designed to unify technical teams, reduce development barriers, and advance innovations with near-term market potential.

Market Opportunity

Xeriant operates at the intersection of several rapidly expanding sectors, including advanced aerospace systems, sustainable construction materials, and next-generation industrial technologies. Demand for eco-friendly building materials continues to accelerate, with the green construction market projected to reach $1.8 trillion by 2030, according to a World Economic Forum report, supported by rising global standards for safety, sustainability, and carbon reduction. NEXBOARD also participates in the broader fire-protection materials market, which is projected to grow from $37.69 billion in 2025 to $59.9 billion by 2034, according to Market Research Future, driven by stricter building codes and increasing awareness of fire-resistant alternatives.

Xeriant plans to capitalize on opportunities emerging from green construction, modular homebuilding, advanced composites engineering, nanotechnology, thermal-management innovations, and cross-disciplinary integration for new product development. Each prospective technology undergoes rigorous due diligence, including market forecasting, management evaluation, competitive assessment, and financial analysis, allowing Xeriant to pursue selective, strategically aligned acquisitions and partnerships.

Leadership Team

Keith F. Duffy, Chairman and Chief Executive Officer, has more than 30 years of experience across investment banking, finance, strategic planning, and operations, and has served as a principal in multiple start-ups spanning aviation, software, banking, and biotech. He arranged the merger that created Xeriant, established the company’s partnership with Florida Atlantic University, and previously held roles ranging from securities broker to controller of an aviation FBO. He is a licensed real estate and mortgage professional and holds a B.A. in Business Administration and Mathematics from Rollins College.

Scott M. Duffy, Executive Director of Corporate Operations, has built a career of over 30 years in management, operations, strategic planning, IT, marketing, and distribution, including oversight of a $545 million retail sales division at American Media. He has collaborated on business development efforts for several start-ups, including Xeriant, and has held senior roles supporting large-scale operational and administrative functions. He earned a B.A. in Business Administration and Mathematics from Rollins College.

Pablo Lavigna, Chief Information Officer, has more than 20 years of experience in information technology and software engineering, supporting Xeriant through technology sourcing, internal systems management, and the development of security and software solutions. His background includes directing IT operations for private firms and implementing network security and specialized software tools across multiple industries. He holds Microsoft and CompTIA certifications and graduated magna cum laude from Florida International University with a degree in Information Technology and Business.

Brian Carey, Chief Financial Officer, has spent over 30 years in accounting, tax, financial management, and business development, having founded and operated a long-standing accounting and advisory firm serving start-ups and established companies. His experience includes business planning, financial oversight, and operational support for partner organizations. He holds a Bachelor of Accounting degree from Penn State University.

Brig. Gen. (Ret.) Blaine D. Holt, President of Factor X Research Group, has a distinguished background in multinational operations, aerospace leadership, and technology-driven enterprise, including service as Deputy U.S. Military Representative to NATO and as a command pilot with more than 3,900 flight hours. His experience spans advanced manufacturing, AI-enabled logistics, large-scale aviation turnarounds, and advisory work supporting emerging technologies, strengthening Xeriant’s ability to evaluate and advance high-impact innovations.

Xeriant Inc. (OTCQB: XERI), closed Tuesday's trading session at $0.0056, up 3.7037%, on 4,601,196 volume. The average volume for the last 3 months is 1,936,680 and the stock's 52-week low/high is $0.003735/$0.01603.

Recent News

• Xeriant Inc. (OTCQB: XERI) - TechMediaBreaks - Xeriant, Inc. (OTCQB: XERI) Notice Of Allowance For Fire-Resistant Composite Patent
• NetworkNewsBreaks - Xeriant Inc. (XERI) Advances Cost-Effective Construction with NEXBOARD(TM) Technology
• InvestorNewsBreaks -Xeriant Inc. (XERI) Positions Factor X at Forefront of Advanced Research Under Brig. Gen. Holt

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)

The QualityStocks Daily Newsletter would like to spotlight Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO).

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators.

At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.

Cardio Diagnostics was founded to develop and commercialize clinical tests and data solutions that enable earlier detection and more precise management of cardiovascular disease across clinical and non-clinical settings.

The company is headquartered in Chicago, Illinois.

Portfolio

The company’s portfolio brings together epigenetic and genetic insights with artificial intelligence to generate actionable information for cardiovascular care. This approach underpins a suite of blood-based tests and platforms designed for use across both individual patient care and broader population health settings.

Epi+Gen CHD™

Epi+Gen CHD™ is a prescription-only blood test that assesses a patient’s three-year risk of a coronary heart disease (CHD) event, including heart attack and sudden death. The test evaluates three epigenetic and five genetic biomarkers and applies artificial intelligence to generate a personalized risk score. It is designed to assess risk regardless of the presence of traditional factors and is non-invasive, requiring no fasting or radiation. In clinical validation studies, the test has demonstrated approximately two times greater sensitivity than conventional risk calculators and enables ongoing monitoring through epigenetic biomarkers that can change in response to intervention.

PrecisionCHD™

PrecisionCHD™ is a prescription-only blood test that aids in the detection and management of coronary heart disease by identifying molecular signals associated with the condition. The test evaluates 10 epigenetic and six genetic biomarkers and uses artificial intelligence to determine whether a disease signal is present. It provides patient-specific insights into the molecular drivers of disease, supporting more individualized care decisions, and is designed to detect both obstructive and non-obstructive forms of CHD in a non-invasive manner.

HeartRisk™

HeartRisk™ is a population-level cardiovascular risk intelligence platform that integrates anonymized clinical, claims, industry, and geographic data to provide real-time insights into heart disease risk across defined populations. The platform enables organizations to quantify risk, project future healthcare costs, benchmark against peer groups, and track changes over time, supporting more informed planning and risk management strategies.

CardioInnovate360™

CardioInnovate360™ is a biopharma research platform that leverages artificial intelligence and epigenetics to support the discovery, development, and validation of cardiovascular therapies. The platform is designed to identify novel biomarkers and disease pathways, optimize clinical trial design through improved patient stratification, and enable the development of scalable, non-invasive diagnostic tools.

Market Opportunity

Cardiovascular disease (CVD) is the leading cause of death in the United States, responsible for nearly one in three deaths. It encompasses a range of conditions, including CHD, stroke, heart failure, and peripheral artery disease, and continues to represent a significant and persistent healthcare burden.

Coronary heart disease is the most common form of CVD and often develops without symptoms, with a heart attack frequently serving as the first indication of disease. In the U.S., one in 20 adults over the age of 20 lives with CHD, and it is the second leading cause of hospitalization, adding approximately $13,000 in annual healthcare costs per patient. An additional three to four million Americans are affected by ischemia with no obstructive coronary arteries (INOCA), a subset of CHD.

Heart attacks occur approximately every 40 seconds in the U.S., with more than 800,000 events annually, and one in five occurring without warning. While an estimated 80–90% of cardiovascular disease is preventable through early detection and proactive management, traditional approaches can leave gaps, as approximately 50% of individuals with coronary heart disease do not present with traditional risk factors and conventional risk calculators have an average sensitivity of 39%.

Leadership Team

Meesha Dogan, PhD, Chief Executive Officer and Co-Founder, has served as CEO and a director since inception and co-founded the company alongside Dr. Philibert. She has more than a decade of experience working at the intersection of artificial intelligence, epigenetics, and genetics, leading the development and commercialization of DNA-based cardiovascular tests. Dr. Dogan is an inventor on multiple granted and pending patents and holds a PhD in Biomedical Engineering and BSE/MS degrees in Chemical Engineering from the University of Iowa.

Robert Philibert, MD, PhD, Chief Medical Officer and Co-Founder, has served as CMO and a director since inception and co-founded the company with Dr. Dogan. He is a professor at the University of Iowa with joint appointments across psychiatry, neuroscience, molecular medicine, and biomedical engineering, and has published more than 200 peer-reviewed manuscripts. Dr. Philibert has received numerous NIH grants and holds patents related to epigenetics, including work on behavioral biomarkers.

Tim Dogan, PhD, Chief Technology Officer, has served as CTO since May 2022 after joining the company in 2019 as its first employee. He played a key role in developing the company’s Integrated Multi-Omics Engine™ and is a co-inventor on multiple patent-pending technologies. Dr. Dogan holds a PhD and BSE/MS degrees in Mechanical Engineering from the University of Iowa.

Elisa Luqman, JD, MBA, Chief Financial Officer, has served as CFO since March 2021 and has experience in public company finance, compliance, and corporate governance. She has held senior leadership roles at Clinigence Holdings Inc. and currently serves as Chief Legal Officer (SEC) at Nutex Health Inc., overseeing SEC reporting and compliance. Ms. Luqman holds a JD and MBA in Finance from Hofstra University.

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), closed Tuesday's trading session at $2.03, up 2.5253%, on 63,663 volume. The average volume for the last 3 months is 489,218 and the stock's 52-week low/high is $0.97/$17.388.

Recent News

• Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) - Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is 'One to Watch'
• BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
• Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.

With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.

Operations

Nightfood Holdings is focused on two core business areas:

• Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
• Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.

Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.

Market Opportunity

The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.

• Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
• Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
• Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.

Industry Impact: The Future of Smart Hotels

NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.

Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:

• Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
• Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
• Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.

Future Vision & Growth Strategy

Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.

Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.

Team Expertise as a Strategic Advantage

In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.

This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Tuesday's trading session at $0.0292, off by 0.6802721%, on 195,171 volume. The average volume for the last 3 months is 513,870 and the stock's 52-week low/high is $0.0112/$0.114.

Recent News

• Nightfood Holdings Inc. (OTCQB: NGTF) - TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Enters Robotics And AI Biopharma Partnership With Oncotelic Therapeutics (OTCQB: OTLC)
• AINewsBreaks - Nightfood Holdings Inc. (NGTF) Leveraging AI Robotics to Transform Beverage Service at Scale
• Automation Without the Capital Expense: The Economics of RaaS Deployment

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Tuesday's trading session at $0.38, off by 1.3756%, on 66,012 volume. The average volume for the last 3 months is 98,840 and the stock's 52-week low/high is $0.0631/$0.62.

Recent News

• LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) - MiningNewsBreaks - LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Files NI 43-101 Technical Report Supporting Swanson Gold Project PEA
• LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Executives Outline Positive PEA Results Plus Company's Next Steps to Production in Investor Webinar
• LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Strengthens Board of Directors, Prepares Live Webinar on Gold Operation in Abitibi

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Datavault AI Inc. (NASDAQ: DVLT), closed Tuesday's trading session at $0.6955, off by 5.387%, on 29,453,787 volume. The average volume for the last 3 months is 45,502,638 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

• Datavault AI Inc. (NASDAQ: DVLT) - MissionIRNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) CEO To Headline Major European Financial Innovation Events
• DefenseNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) to Showcase RWA Tokenization Technologies at XRP Tokyo 2026
• Web3MediaBreaks - Datavault AI Inc. (NASDAQ: DVLT) Partners With Demora Foundation To Power K-Entertainment Tokenization Platform

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (https://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Tuesday's trading session at $2.18, off by 6.0345%, on 17,118 volume. The average volume for the last 3 months is 43,481 and the stock's 52-week low/high is $2.0573/$34.7988.

Recent News

• CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - Researchers Solve 50-Year-Old Challenge in Making Cancer Drug
• Researchers Discover Mechanism Behind Deadly Pediatric Brain Cancer
• Misinformation Could Thwart the Potential of Cancer Vaccines